References
- 1. Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction. Molecular and Pathophysiological Mechanisms. Circulation. 2006;113:1888-1904.10.1161/CIRCULATIONAHA.105.563213
- 2. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135.10.1161/hc0902.104353
- 3. Lee HM, Kim JJ, Kim HJ, Shong M, Ku BJ, Jo EK.Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes. 2013;62:194-204.10.2337/db12-0420
- 4. Stefan G, Garneata L, Tacu D, et al. Transplantation in Romania: Where Do We Stand? Maedica (Buchar). 2015;4:304+309.
- 5. Fowkes FG, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382:1329-40.10.1016/S0140-6736(13)61249-0
- 6. Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC).J Vasc Surg. 2000;31:S1-S296.
- 7. Murphy TP, Cutlip DE, Regensteiner JG, et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the clever study. J Am Coll Cardiol. 2015;65:999-1009. 10.1016/j.jacc.2014.12.043.
- 8. Kang G. Endovascular approach to iliac artery stenosis and restenosis. Indian Heart J. 2015;67(6):514-517. doi:10.1016/j.ihj.2015.09.034.10.1016/j.ihj.2015.09.034469996826702677
- 9. Cronewett Jack K., Wayne Johnston. 8th ed. 2 vol. Saunders/Elsevier; Philadelphia, PA: 2014. (Rutherford’s Vascular Surgery).